LogicBio Therapeutics (LOGC) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $9.02 -3.22%
EPS Growth %: +82.6%
Financial Fact:
Loss from operations: -140.8K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +82.6%
Financial Fact:
Loss from operations: -140.8K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.04).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
- Avis Budget Group reaches $650M settlement with Pentwater Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
